or Try an Advanced Search...

    Technical Analysis for PBM - Psyence Biomedical Ltd.

    Grade Last Price % Change Price Change
    F 0.30 1.21% 0.00
    PBM closed up 1.21 percent on Wednesday, July 3, 2024, on 11 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical PBM trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish 1.21%
    Wide Bands Range Expansion 1.21%
    Oversold Stochastic Weakness 1.21%
    Narrow Range Bar Range Contraction -5.45%
    Wide Bands Range Expansion -5.45%
    Oversold Stochastic Weakness -5.45%
    Older End-of-Day Signals for PBM ...

       Recent Intraday Alerts

    Alert Time
    Down 5% about 10 hours ago
    Down 3% about 10 hours ago
    Up 5% about 10 hours ago
    Up 3% about 10 hours ago
    Down 2 % about 10 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    PBM Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Psyence is a life science biotechnology company with a focus on natural psychedelics. The Psyence Biomed Division works with natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. Our name “Psyence” combines the words psychedelic and science to affirm our commitment to producing psychedelic medicines developed through evidence-based research.
    Classification
    Sector: Other
    Industry: Other
    Keywords: Biotechnology Entheogens Psychedelic Drug Psilocybin

    Is PBM a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 17 Psyence Biomed to Participate in the A.G.P. Virtual Healthcare Company Showcase
    Apr 16 Psyence Group's NASDAQ Listed Associate, Psyence Biomedical Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial
    Apr 8 Psyence Biomed Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial
    Mar 26 Psyence Group Announces the Closing of the Previously Announced Strategic Restructuring of Its Non-Clinical Business
    Mar 18 Psyence Biomedical Welcomes Results of a Recent Study Highlighting Benefits of Nature Derived Psilocybin Vs. Synthetic Psilocybin
    Mar 15 Psyence Biomedical gets non-compliance notification from Nasdaq
    Mar 15 Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares
    Mar 12 Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study
    Mar 12 Psyence Biomedical Ltd. Issues Shareholder Letter Recapping Recent Progress and Outlining Key Future Milestones
    Mar 11 Psyence Biomedical Will Undertake Psilocybin Clinical Trials For Palliative Care In Australia
    See more PBM news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 14.55
    52 Week Low 0.2666
    Average Volume 500,198
    200-Day Moving Average 5.28
    50-Day Moving Average 0.75
    20-Day Moving Average 0.51
    10-Day Moving Average 0.36
    Average True Range 0.07
    RSI (14) 17.36
    ADX 38.73
    +DI 8.09
    -DI 35.13
    Chandelier Exit (Long, 3 ATRs) 0.58
    Chandelier Exit (Short, 3 ATRs) 0.48
    Upper Bollinger Bands 0.82
    Lower Bollinger Band 0.19
    Percent B (%b) 0.18
    BandWidth 125.40
    MACD Line -0.14
    MACD Signal Line -0.12
    MACD Histogram -0.0124
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.35
    Resistance 3 (R3) 0.35 0.33 0.34
    Resistance 2 (R2) 0.33 0.32 0.33 0.34
    Resistance 1 (R1) 0.32 0.31 0.32 0.32 0.34
    Pivot Point 0.30 0.30 0.30 0.30 0.30
    Support 1 (S1) 0.28 0.29 0.29 0.29 0.27
    Support 2 (S2) 0.27 0.28 0.27 0.26
    Support 3 (S3) 0.25 0.27 0.26
    Support 4 (S4) 0.25